| |
 |
|
|
| Home > General Information
> Agenda / Program |
 |
|
[Day I] Oct. 8 (Friday)
| 13:30 ~ 14:00 |
Registration |
|
14:00 ~ 14:05
|
Opening Remarks
|
Joobae Park, MD, PhD
Director, SBRI |
|
14:05 ~ 14:10
|
Welcome Address
|
Jongchul Rhee, MD, PhD
President & CEO, Samsung Medical
Center |
| |
|
|
|
|
Overview
|
Chair
:Joobae Park, MD, PhD |
|
|
| 14:10
~ 14:50 |
The Pathogenesis of Cancer Metastasis |
| |
Isaiah J Fidler, DVM, PhD |
|
|
|
Session I Cancer Stem Cell & Niche
: Revisit of Seed and Soil Theory ? |
Chair
:Keunchil Park, MD, PhD |
|
|
| 14:50
~ 15:15 |
Interactive Role of VEGF-A and Angiopoietin-2 in Tumor Angiogenesis and Metastasis |
| |
Gou Young Koh, MD, PhD |
| 15:15
~ 15:35 |
Coffee Break |
| |
|
| 15:35
~ 16:15 |
Stem cells and their Niche |
| |
Toshio Suda, MD, PhD |
| 16:15
~ 16:55 |
Targeting the Organ Microenvironment for Treatment of Metastasis |
| |
Isaiah J Fidler, DVM, PhD |
|
[Day II] Oct. 9 (Saturday)
| 08:40 ~ 09:00 |
Registration |
|
|
| Session II Role of Cancer Stem Cell in Metastasis |
Chair
: Il-Hoan Oh, MD, PhD |
|
|
| 09:00
~ 09:40 |
Mechanisms of cancer drug resistance revealed through functional genetic approaches |
| |
Rene Bernards, PhD |
09:40 ~ 10:05
|
Discovery of A Novel Factor in Cancer Metastasis |
| |
Sunghoon Kim, PhD |
10:05 ~ 10:45
|
TGF-beta signaling in regulation of cancer-initiating cells |
| |
Kohei Miyazono, MD, PhD |
10:45 ~ 11:05
|
Coffee Break |
|
|
| Session III Targeted Therapy Against Cancer Stem Cell |
Chair
: Jin Cheon Kim, MD, PhD |
|
|
| 11:05 ~ 11:30 |
Personalized drug discovery based on cancer stem cell biology |
| |
Do-Hyun Nam , MD , PhD |
| 11:30 ~ 12:10 |
Role of the polycomb proteins in normal and cancer stem cells |
| |
Atsushi Iwama, MD, PhD
|
| 12:10 ~ 12:50 |
Targeting the Hedgehog Pathway in Cancer |
| |
Frederic J. de Sauvage, PhD
|
| 12:50 ~ 12:55 |
Closing Remarks |
| |
Byung-Tae Kim, MD, PhD,
Chairman, SISMM
|
|
|
|
|
|
|
|
|
|
 |
|
|
